Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
Doyle Janeen Noel has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.
On the most recent filing, Doyle Janeen Noel is listed as Chief Corp. & Bus. Dev. Ofcr at Janux Therapeutics, Inc. Inside the rolling window, Doyle Janeen Noel reported no open-market purchases and 1 open-market sale totaling $57K in JANX.
Companies traded
Other insiders at JANX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$57K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Doyle Janeen Noel made?
Doyle Janeen Noel has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Doyle Janeen Noel trade?
Doyle Janeen Noel has filed SEC Form 4 disclosures for 1 company, including JANX.
When was Doyle Janeen Noel's most recent SEC Form 4 filing?
Doyle Janeen Noel's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.
What is Doyle Janeen Noel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Doyle Janeen Noel is listed as Chief Corp. & Bus. Dev. Ofcr.
What is Doyle Janeen Noel's total buy and sell value in the current window?
Inside the rolling retention window, Doyle Janeen Noel bought $0 and sold $57K based on SEC Form 4 filings.
What was Doyle Janeen Noel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,059 JANX shares on 2026-06-02, worth $57K, per SEC Form 4 filings.